NexImmune, Inc.
NASDAQ:NEXI
0.205 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|
Assets: | ||||||
Current Assets: | ||||||
Cash & Cash Equivalents
| 3.202 | 34.642 | 30.326 | 5.031 | 9.129 | 0.426 |
Short Term Investments
| 1.444 | 0 | 51.492 | 0 | 1.007 | 11.634 |
Cash and Short Term Investments
| 4.646 | 34.642 | 81.818 | 5.031 | 10.136 | 12.06 |
Net Receivables
| 0 | 0.074 | 0 | 0 | 0.006 | 0.074 |
Inventory
| 0 | -0.019 | 0 | 0 | 0.061 | 0 |
Other Current Assets
| 0.754 | 2.652 | 4.395 | 2.341 | 0.894 | 0.2 |
Total Current Assets
| 5.401 | 37.369 | 86.281 | 8.392 | 11.037 | 12.334 |
Non-Current Assets: | ||||||
Property, Plant & Equipment, Net
| 1.4 | 5.426 | 4.427 | 2.885 | 2.578 | 1.695 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1.793 | 0.265 | 0.324 | 0.023 | 0.104 | 0.114 |
Total Non-Current Assets
| 3.193 | 5.691 | 4.751 | 2.909 | 2.682 | 1.809 |
Total Assets
| 8.594 | 43.06 | 91.032 | 11.301 | 13.718 | 14.142 |
Liabilities & Equity: | ||||||
Current Liabilities: | ||||||
Account Payables
| 1.336 | 2.377 | 1.045 | 2.76 | 1.172 | 0.861 |
Short Term Debt
| 0.069 | 0.599 | 0 | 19.118 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 2.603 | 0 | 0 |
Other Current Liabilities
| 3.679 | 7.357 | 6.171 | 5.149 | 1.853 | 2.142 |
Total Current Liabilities
| 5.084 | 10.334 | 7.216 | 27.027 | 3.025 | 3.003 |
Non-Current Liabilities: | ||||||
Long Term Debt
| 0 | 0.426 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0.056 | 0.028 | 0.082 | 0.329 |
Total Non-Current Liabilities
| 0 | 0.426 | 0.056 | 0.028 | 0.082 | 0.329 |
Total Liabilities
| 5.084 | 10.759 | 7.271 | 27.055 | 3.107 | 3.332 |
Equity: | ||||||
Preferred Stock
| 0 | 0 | 91,032.116 | 53.621 | 53.621 | 35.047 |
Common Stock
| 0.003 | 0.003 | 0.002 | 0 | 0 | 0 |
Retained Earnings
| -222.594 | -190.25 | -127.743 | -77.582 | -47.716 | -27.169 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0.003 | 0 | 0.001 | -0.03 |
Other Total Stockholders Equity
| 226.101 | 222.548 | -90,820.617 | -45.414 | 4.706 | 2.962 |
Total Shareholders Equity
| 3.51 | 32.3 | 83.761 | -15.754 | 10.611 | 10.81 |
Total Equity
| 3.51 | 32.3 | 83.761 | -15.754 | 10.611 | 10.81 |
Total Liabilities & Shareholders Equity
| 8.594 | 43.06 | 91.032 | 11.301 | 13.718 | 14.142 |